Authors: Tjan-Heijnen, VCG Postmus, PE Ardizzoni, A Manegold, C Burghouts, J van Meerbeeck, J Gans, S Mollers, M Buchholz, E Biesma, B Legrand, C Debruyne, C Giaccone, G

Citation: Vcg. Tjan-heijnen et al., Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study, ANN ONCOL, 12(10), 2001, pp. 1359-1368

Authors: Groen, HJM Fokkema, E Biesma, B Kwa, B van Putten, JWG Postmus, PE Smit, EF

Citation: Hjm. Groen et al., Paclitaxel and carboplatin in the treatment of small-cell lung cancer patients resistant to cyclophosphamide, doxorubicin, and etoposide: A non-cross-resistant schedule, J CL ONCOL, 17(3), 1999, pp. 927-932

Authors: Tjan-Heijnen, VCG Biesma, B Festen, J Splinter, TAW Cox, A Wagener, DJT Postmus, PE

Citation: Vcg. Tjan-heijnen et al., Detrimental effects of prechemotherapy filgrastim - In reply, J CL ONCOL, 17(3), 1999, pp. 1089-1090

Authors: Biesma, B Smit, EF Postmus, PE

Citation: B. Biesma et al., A dose and schedule finding study of gemcitabine and etoposide in patientswith progressive non-small cell lung cancer after platinum containing chemotherapy, LUNG CANC, 24(2), 1999, pp. 115-121